ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GA21253-1mg |
|
851538-67-5 |
Cdc25A (80-93) (human)
|
0 | C60H90N14O24S | |
GA21253-005mg |
|
851538-67-5 |
Cdc25A (80-93) (human)
|
0 | C60H90N14O24S | |
GA21252-5mg |
|
143257-75-4 |
CD36 (93-110)-Cys
|
0 | C96H151N29O33S | |
GA21252-1mg |
|
143257-75-4 |
CD36 (93-110)-Cys
|
0 | C96H151N29O33S | |
GA21251-5mg |
|
1351804-17-5 |
CBP501 Affinity Peptide
|
0 | C68H119N21O25S | |
GA21251-1mg |
|
1351804-17-5 |
CBP501 Affinity Peptide
|
0 | C68H119N21O25S | |
GA21250-5mg |
|
775289-20-8 |
Caspase-3/7 Inhibitor II
|
0 | C20H31N5O10 | |
GA21250-1mg |
|
775289-20-8 |
Caspase-3/7 Inhibitor II
|
0 | C20H31N5O10 | |
GA21249-1mg |
|
209615-75-8 |
CART (61-102) (human, rat)
|
0 | C189H310N58O56S7 | |
GA21249-005mg |
|
209615-75-8 |
CART (61-102) (human, rat)
|
0 | C189H310N58O56S7 | |
GA21249-001mg |
|
209615-75-8 |
CART (61-102) (human, rat)
|
0 | C189H310N58O56S7 | |
GA21248-1mg |
|
1815618-15-5 |
CART (55-76) (rat)
|
0 | C107H166N26O33S3 | |
GA21248-005mg |
|
1815618-15-5 |
CART (55-76) (rat)
|
0 | C107H166N26O33S3 | |
GA21247-500mg |
|
81109-85-5 |
Carboxymethyl-Phe-Leu-OH
|
0 | C17H24N2O5 | |
GA21247-100mg |
|
81109-85-5 |
Carboxymethyl-Phe-Leu-OH
|
0 | C17H24N2O5 | |
GA21246-5g |
|
77340-50-2 |
Carbamoyl-DL-Ala-OH
|
0 | C4H8N2O3 | |
GA21246-1g |
|
77340-50-2 |
Carbamoyl-DL-Ala-OH
|
0 | C4H8N2O3 | |
GA21245-5g |
|
13184-27-5 |
Carbamoyl-Asp-OH . magnesium salt/Carbamoyl-Asp-OH . dipotassium salt (1:1)
|
0 | C10H12K2MgN4O10 | |
GA21245-1g |
|
13184-27-5 |
Carbamoyl-Asp-OH . magnesium salt/Carbamoyl-Asp-OH . dipotassium salt (1:1)
|
0 | C10H12K2MgN4O10 | |
GA21244-5mg |
|
100853-58-5 |
cAMP-Dependent Protein Kinase Inhibitor-α (5-22) amide (human, mouse, rabbit, rat)
|
0 | C84H137N29O26 | |